speb/financial-data huggingface dataset:
PRCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 78154000.00
PRCT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -27438000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Work In Process: 10898000.00
PRCT balance_sheet (quarterly, 2025-03-31) — Working Capital: 413727000.00
PRCT income_statement (quarterly, 2025-06-30) — +Operating Expense: 73935000.00
PRCT income_statement (quarterly, 2025-06-30) — +Total Revenue: 79182000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 11783000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 80817000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -10647000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 976240000.00
PRCT cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 160000.00
PRCT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 55445000.00
PRCT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.35
PRCT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 319245000.00
PRCT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2802000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 27843000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
PRCT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 302717000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 302717000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 289686000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Cash Financial: 13031000.00
PRCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 4378000.00
PRCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2802000.00
PRCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -15043000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2250000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1340000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Interest Payable: 27000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Inventory: -4786000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -770000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -829000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -12000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Payable: -2250000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -910000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 513000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -2706000.00
PRCT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9500000.00
PRCT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -2706000.00
PRCT cash_flow (quarterly, 2025-06-30) — Changes In Cash: -13467000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
PRCT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 385796000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 1876000.00
PRCT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 27436000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Current Assets: 458067000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2059000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2059000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 9889000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 9889000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 49727000.00
PRCT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1588000.00
PRCT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1588000.00
PRCT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 55445000.00
PRCT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.35
PRCT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -19578000.00
PRCT income_statement (quarterly, 2025-06-30) — EBIT: -18683000.00
PRCT income_statement (quarterly, 2025-06-30) — EBITDA: -17095000.00
PRCT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -23000.00
PRCT cash_flow (quarterly, 2025-06-30) — End Cash Position: 305755000.00
PRCT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4378000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Finished Goods: 36992000.00
PRCT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -17845000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -144000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 795000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 57509000.00
PRCT income_statement (quarterly, 2025-06-30) — Gross Profit: 51746000.00
PRCT income_statement (quarterly, 2025-06-30) — Interest Expense: 895000.00
PRCT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 895000.00
PRCT income_statement (quarterly, 2025-06-30) — Interest Income: 3506000.00
PRCT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3506000.00
PRCT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 869000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Inventory: 67032000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 437320000.00
PRCT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2802000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Leases: 12488000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
PRCT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 25784000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 51524000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 77308000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 21265000.00
PRCT cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -348000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Income: -19578000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -19578000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -19578000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -19578000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -19578000.00
PRCT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -19579000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -19578000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Interest Income: 2611000.00
PRCT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 2611000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Net PPE: 46862000.00
PRCT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2802000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 385001000.00
PRCT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -17095000.00
PRCT income_statement (quarterly, 2025-06-30) — Normalized Income: -19578000.00
PRCT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -15043000.00
PRCT income_statement (quarterly, 2025-06-30) — Operating Income: -22189000.00
PRCT income_statement (quarterly, 2025-06-30) — Operating Revenue: 79182000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 55577000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7501000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 9694000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -144000.00
PRCT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -127000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 7330000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 223000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Other Properties: 21880000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Payables: 11783000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 11783000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 16302000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
PRCT income_statement (quarterly, 2025-06-30) — Pretax Income: -19578000.00
PRCT cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 4378000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
PRCT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 600000.00
PRCT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2802000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Raw Materials: 17080000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Receivables: 80817000.00
PRCT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 27436000.00
PRCT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1588000.00
PRCT income_statement (quarterly, 2025-06-30) — Research And Development: 17632000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -590300000.00
PRCT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 56303000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Share Issued: 55577000.00
PRCT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 12163000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 385796000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 385001000.00
PRCT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Assets: 513054000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 437320000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Debt: 79367000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 385796000.00
PRCT income_statement (quarterly, 2025-06-30) — Total Expenses: 101371000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 127258000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 54987000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 77531000.00
PRCT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -22189000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Work In Process: 12960000.00
PRCT balance_sheet (quarterly, 2025-06-30) — Working Capital: 408340000.00
PRCT income_statement (quarterly, 2025-09-30) — +Operating Expense: 77198000.00
PRCT income_statement (quarterly, 2025-09-30) — +Total Revenue: 83327000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 11118000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 84504000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -12197000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 991945000.00
PRCT cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 76000.00
PRCT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 55727000.00
PRCT income_statement (quarterly, 2025-09-30) — Basic EPS: -0.38
PRCT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 305755000.00
PRCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2868000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 27360000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
PRCT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 294281000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 294281000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 287222000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Cash Financial: 7059000.00
PRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1077000.00
PRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2868000.00
PRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -6635000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -789000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 5497000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Interest Payable: 42000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Inventory: 568000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -808000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1520000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1129000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Payable: -789000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4708000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1760000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4351000.00
PRCT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2034000.00
PRCT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -4351000.00
PRCT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -8426000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
PRCT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 380276000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 3738000.00
PRCT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 29321000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Current Assets: 454752000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2135000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2135000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 10665000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 10665000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 53898000.00
PRCT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1618000.00
PRCT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1618000.00
PRCT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 55727000.00
PRCT income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.38
PRCT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — EBIT: -20492000.00
PRCT income_statement (quarterly, 2025-09-30) — EBITDA: -18874000.00
PRCT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -10000.00
PRCT cash_flow (quarterly, 2025-09-30) — End Cash Position: 297319000.00
PRCT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1077000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Finished Goods: 35513000.00
PRCT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -9503000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 42000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 727000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 60123000.00
PRCT income_statement (quarterly, 2025-09-30) — Gross Profit: 54006000.00
PRCT income_statement (quarterly, 2025-09-30) — Interest Expense: 919000.00
PRCT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 919000.00
PRCT income_statement (quarterly, 2025-09-30) — Interest Income: 2700000.00
PRCT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2700000.00
PRCT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 878000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Inventory: 66715000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 431842000.00
PRCT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2868000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Leases: 13024000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
PRCT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 25225000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 51566000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 76791000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 21470000.00
PRCT cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 227000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Income: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -21411000.00
PRCT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -21411000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Interest Income: 1781000.00
PRCT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1781000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Net PPE: 47926000.00
PRCT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2868000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 379549000.00
PRCT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -18874000.00
PRCT income_statement (quarterly, 2025-09-30) — Normalized Income: -21411000.00
PRCT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -6635000.00
PRCT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 227000.00
PRCT income_statement (quarterly, 2025-09-30) — Operating Income: -23192000.00
PRCT income_statement (quarterly, 2025-09-30) — Operating Revenue: 83327000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 55870000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 9252000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 8183000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 42000.00
PRCT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -127000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 8136000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 576000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Other Properties: 21891000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Payables: 11118000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 11118000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 21797000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
PRCT income_statement (quarterly, 2025-09-30) — Pretax Income: -21411000.00
PRCT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1077000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
PRCT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 526000.00
PRCT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2868000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Raw Materials: 18388000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Receivables: 84504000.00
PRCT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 29321000.00
PRCT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1618000.00
PRCT income_statement (quarterly, 2025-09-30) — Research And Development: 18187000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -611711000.00
PRCT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 59011000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Share Issued: 55870000.00
PRCT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 14490000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 380276000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 379549000.00
PRCT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Assets: 511541000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 431842000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Debt: 78926000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 380276000.00
PRCT income_statement (quarterly, 2025-09-30) — Total Expenses: 106519000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 131265000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 56789000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 77367000.00
PRCT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -23192000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Work In Process: 12814000.00
PRCT balance_sheet (quarterly, 2025-09-30) — Working Capital: 400854000.00
PRCT income_statement (annual, 2025-12-31) — +Operating Expense: 300085000.00
PRCT income_statement (quarterly, 2025-12-31) — +Operating Expense: 77354000.00
PRCT income_statement (annual, 2025-12-31) — +Total Revenue: 308054000.00
PRCT income_statement (quarterly, 2025-12-31) — +Total Revenue: 76383000.00
PRCT balance_sheet (annual, 2025-12-31) — Accounts Payable: 17285000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 17285000.00
PRCT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 83533000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 83533000.00
PRCT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -12752000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -12752000.00
PRCT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1007390000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1007390000.00
PRCT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 565000.00
PRCT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -1000.00
PRCT income_statement (annual, 2025-12-31) — Basic Average Shares: 55544000.00
PRCT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 56071000.00
PRCT income_statement (annual, 2025-12-31) — Basic EPS: -1.72
PRCT income_statement (quarterly, 2025-12-31) — Basic EPS: -0.53
PRCT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 336763000.00
PRCT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 297319000.00
PRCT cash_flow (annual, 2025-12-31) — Capital Expenditure: -9356000.00
PRCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1850000.00
PRCT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 26868000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 26868000.00
PRCT balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
PRCT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
PRCT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 286503000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 286503000.00
PRCT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 286503000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 286503000.00
PRCT balance_sheet (annual, 2025-12-31) — Cash Equivalents: 275086000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 275086000.00
PRCT balance_sheet (annual, 2025-12-31) — Cash Financial: 11417000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Cash Financial: 11417000.00
PRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11193000.00
PRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 4440000.00
PRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9356000.00
PRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1850000.00
PRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -48985000.00
PRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10327000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Account Payable: 6648000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 5933000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1732000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 1431000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Interest Payable: 142000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Interest Payable: 48000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Inventory: -14498000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Inventory: -3998000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2895000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -922000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -132000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 1827000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 3306000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 1954000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Payable: 6648000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Payable: 5933000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 8380000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 7364000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1102000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -431000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Receivables: -898000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2230000.00
PRCT cash_flow (annual, 2025-12-31) — Change In Working Capital: -7839000.00
PRCT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 8024000.00
PRCT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -898000.00
PRCT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 2230000.00
PRCT cash_flow (annual, 2025-12-31) — Changes In Cash: -47148000.00
PRCT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -7737000.00
PRCT balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
PRCT balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
PRCT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 365870000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 365870000.00
PRCT cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
PRCT balance_sheet (annual, 2025-12-31) — Construction In Progress: 4109000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 4109000.00
PRCT income_statement (annual, 2025-12-31) — Cost Of Revenue: 111828000.00
PRCT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 30070000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1230000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1230000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Assets: 450378000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Assets: 450378000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2214000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2214000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2214000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2214000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 13048000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 13048000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 13048000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 13048000.00
PRCT balance_sheet (annual, 2025-12-31) — Current Liabilities: 65795000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 65795000.00
PRCT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 6390000.00
PRCT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1709000.00
PRCT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 6390000.00
PRCT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1709000.00
PRCT income_statement (annual, 2025-12-31) — Diluted Average Shares: 55544000.00
PRCT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 56071000.00
PRCT income_statement (annual, 2025-12-31) — Diluted EPS: -1.72
PRCT income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.53
PRCT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -29845000.00
PRCT income_statement (annual, 2025-12-31) — EBIT: -91796000.00
PRCT income_statement (quarterly, 2025-12-31) — EBIT: -28761000.00
PRCT income_statement (annual, 2025-12-31) — EBITDA: -85406000.00
PRCT income_statement (quarterly, 2025-12-31) — EBITDA: -27052000.00
PRCT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -74000.00
PRCT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -41000.00
PRCT cash_flow (annual, 2025-12-31) — End Cash Position: 289541000.00
PRCT cash_flow (quarterly, 2025-12-31) — End Cash Position: 289541000.00
PRCT cash_flow (annual, 2025-12-31) — Financing Cash Flow: 11193000.00
PRCT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 4440000.00
PRCT balance_sheet (annual, 2025-12-31) — Finished Goods: 38630000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 38630000.00
PRCT cash_flow (annual, 2025-12-31) — Free Cash Flow: -58341000.00
PRCT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -12177000.00
PRCT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 37000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 37000.00
PRCT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 709000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 709000.00
PRCT balance_sheet (annual, 2025-12-31) — Gross PPE: 60689000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 60689000.00
PRCT income_statement (annual, 2025-12-31) — Gross Profit: 196226000.00
PRCT income_statement (quarterly, 2025-12-31) — Gross Profit: 46313000.00
PRCT income_statement (annual, 2025-12-31) — Interest Expense: 3586000.00
PRCT income_statement (quarterly, 2025-12-31) — Interest Expense: 894000.00
PRCT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3586000.00
PRCT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 894000.00
PRCT income_statement (annual, 2025-12-31) — Interest Income: 12219000.00
PRCT income_statement (quarterly, 2025-12-31) — Interest Income: 2436000.00
PRCT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 12219000.00
PRCT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2436000.00
PRCT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3463000.00
PRCT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 831000.00
PRCT balance_sheet (annual, 2025-12-31) — Interest Payable: 291000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Interest Payable: 291000.00
PRCT balance_sheet (annual, 2025-12-31) — Inventory: 70694000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Inventory: 70694000.00
PRCT balance_sheet (annual, 2025-12-31) — Invested Capital: 417485000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 417485000.00
PRCT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -9356000.00
PRCT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1850000.00
PRCT cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
PRCT balance_sheet (annual, 2025-12-31) — Leases: 13225000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Leases: 13225000.00
PRCT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 24654000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 24654000.00
PRCT balance_sheet (annual, 2025-12-31) — Long Term Debt: 51615000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 51615000.00
PRCT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 76269000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 76269000.00
PRCT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 21842000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 21842000.00
PRCT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
PRCT cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 157000.00
PRCT cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 278000.00
PRCT income_statement (annual, 2025-12-31) — Net Income: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Income: -29845000.00
PRCT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -29845000.00
PRCT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -29845000.00
PRCT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -29845000.00
PRCT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -29845000.00
PRCT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -95572000.00
PRCT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -29845000.00
PRCT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -29845000.00
PRCT income_statement (annual, 2025-12-31) — Net Interest Income: 8633000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Interest Income: 1542000.00
PRCT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 8633000.00
PRCT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1542000.00
PRCT balance_sheet (annual, 2025-12-31) — Net PPE: 47937000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Net PPE: 47937000.00
PRCT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -9356000.00
PRCT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1850000.00
PRCT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 365161000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 365161000.00
PRCT income_statement (annual, 2025-12-31) — Normalized EBITDA: -85406000.00
PRCT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -27052000.00
PRCT income_statement (annual, 2025-12-31) — Normalized Income: -95572000.00
PRCT income_statement (quarterly, 2025-12-31) — Normalized Income: -29845000.00
PRCT cash_flow (annual, 2025-12-31) — Operating Cash Flow: -48985000.00
PRCT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -10327000.00
PRCT cash_flow (annual, 2025-12-31) — Operating Gains Losses: 157000.00
PRCT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 278000.00
PRCT income_statement (annual, 2025-12-31) — Operating Income: -103859000.00
PRCT income_statement (quarterly, 2025-12-31) — Operating Income: -31041000.00
PRCT income_statement (annual, 2025-12-31) — Operating Revenue: 308054000.00
PRCT income_statement (quarterly, 2025-12-31) — Operating Revenue: 76383000.00
PRCT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 56323000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 56323000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Current Assets: 9648000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 9648000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 7385000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 7385000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 37000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 37000.00
PRCT income_statement (annual, 2025-12-31) — Other Income Expense: -156000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 709000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 709000.00
PRCT cash_flow (annual, 2025-12-31) — Other Non Cash Items: -508000.00
PRCT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -127000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 9057000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 9057000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 147000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 147000.00
PRCT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -156000.00
PRCT balance_sheet (annual, 2025-12-31) — Other Properties: 21513000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Other Properties: 21513000.00
PRCT balance_sheet (annual, 2025-12-31) — Payables: 18743000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Payables: 18743000.00
PRCT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 19973000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 19973000.00
PRCT balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23175000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 23175000.00
PRCT balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
PRCT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
PRCT income_statement (annual, 2025-12-31) — Pretax Income: -95382000.00
PRCT income_statement (quarterly, 2025-12-31) — Pretax Income: -29655000.00
PRCT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 11193000.00
PRCT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 4440000.00
PRCT balance_sheet (annual, 2025-12-31) — Properties: 0.00
PRCT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PRCT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 219000.00
PRCT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -1207000.00
PRCT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -9356000.00
PRCT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1850000.00
PRCT balance_sheet (annual, 2025-12-31) — Raw Materials: 18617000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 18617000.00
PRCT balance_sheet (annual, 2025-12-31) — Receivables: 83533000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Receivables: 83533000.00
PRCT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 111828000.00
PRCT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 30070000.00
PRCT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 6390000.00
PRCT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1709000.00
PRCT income_statement (annual, 2025-12-31) — Research And Development: 71277000.00
PRCT income_statement (quarterly, 2025-12-31) — Research And Development: 19056000.00
PRCT balance_sheet (annual, 2025-12-31) — Retained Earnings: -641557000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -641557000.00
PRCT income_statement (annual, 2025-12-31) — Selling General And Administration: 228808000.00
PRCT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 58298000.00
PRCT balance_sheet (annual, 2025-12-31) — Share Issued: 56323000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Share Issued: 56323000.00
PRCT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 47603000.00
PRCT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 10842000.00
PRCT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 365870000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 365870000.00
PRCT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 365161000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 365161000.00
PRCT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PRCT income_statement (annual, 2025-12-31) — Tax Provision: 190000.00
PRCT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
PRCT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
PRCT balance_sheet (annual, 2025-12-31) — Total Assets: 508081000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Assets: 508081000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Capitalization: 417485000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 417485000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Debt: 78483000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Debt: 78483000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 365870000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 365870000.00
PRCT income_statement (annual, 2025-12-31) — Total Expenses: 411913000.00
PRCT income_statement (quarterly, 2025-12-31) — Total Expenses: 107424000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 142211000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 142211000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 57703000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 57703000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 76416000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 76416000.00
PRCT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -103859000.00
PRCT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -31041000.00
PRCT balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1458000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1458000.00
PRCT balance_sheet (annual, 2025-12-31) — Work In Process: 13447000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Work In Process: 13447000.00
PRCT balance_sheet (annual, 2025-12-31) — Working Capital: 384583000.00
PRCT balance_sheet (quarterly, 2025-12-31) — Working Capital: 384583000.00
PRCT income_statement (quarterly, 2026-03-31) — +Operating Expense: 86553000.00
PRCT income_statement (quarterly, 2026-03-31) — +Total Revenue: 83132000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 18851000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 96388000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -14418000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1020881000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1254000.00
PRCT cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 274000.00
PRCT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 56511000.00
PRCT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.56
PRCT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 289540000.00
PRCT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2914000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 26332000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
PRCT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 245641000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 245641000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 233412000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Cash Financial: 12229000.00
PRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 222000.00
PRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2914000.00
PRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -38127000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1536000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -4639000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Interest Payable: 49000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Inventory: -7027000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -431000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 180000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 628000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Payable: 1536000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3103000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 1167000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -13317000.00
PRCT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -21903000.00
PRCT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -13317000.00
PRCT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -40819000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
PRCT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 347667000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1483000.00
PRCT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 29185000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Current Assets: 428034000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2358000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2358000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 13702000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 13702000.00
PRCT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 63636000.00
PRCT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1735000.00
PRCT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1735000.00
PRCT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 56511000.00
PRCT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.56
PRCT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -31638000.00
PRCT income_statement (quarterly, 2026-03-31) — EBIT: -30863000.00
PRCT income_statement (quarterly, 2026-03-31) — EBITDA: -29128000.00
PRCT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -42000.00
PRCT cash_flow (quarterly, 2026-03-31) — End Cash Position: 248679000.00